Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients
Yongping Zhou, Wei Qian, Junsheng Fan, et al.
Clinica Chimica Acta (2018) Vol. 479, pp. 181-189
Closed Access | Times Cited: 130

Showing 26-50 of 130 citing articles:

Early-onset pancreatic cancer: Clinical characteristics and survival outcomes
Tsuyoshi Takeda, Takashi Sasaki, Yosuke Inoue, et al.
Pancreatology (2022) Vol. 22, Iss. 4, pp. 507-515
Closed Access | Times Cited: 21
Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?
Constantinos P. Zambirinis, Abhishek Midya, Jayasree Chakraborty, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 8, pp. 4962-4974
Open Access | Times Cited: 19
Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel
Tsuyoshi Takeda, Takashi Sasaki, Takeshi Okamoto, et al.
Pancreatology (2023) Vol. 23, Iss. 3, pp. 275-282
Closed Access | Times Cited: 11
Association between the neutrophil-to-lymphocyte ratio and cancer in adults from NHANES 2005–2018: a cross-sectional study
Gangping Li, Di Zhang, Minghui Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms
Fahimeh Jafarnezhad‐Ansariha, Nicole Contran, Chiara Cristofori, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 643-643
Open Access
Neutrophils in colorectal cancer: mechanisms, prognostic value, and therapeutic implications
Xingyue Wang, Shukang He, Xiangmei Gong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The Diagnostic and Prognostic Role of Inflammatory Markers, Including the New Cumulative Inflammatory Index (IIC) and Mean Corpuscular Volume/Lymphocyte (MCVL), in Colorectal Adenocarcinoma
Robert-Emmanuel Șerban, Dragoş-Marian Popescu, Mihail Virgil Boldeanu, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 990-990
Open Access
Elevated Neutrophil-Lymphocyte Ratio is Predictive of Poor Outcomes Following Aneurysmal Subarachnoid Hemorrhage
Sheheryar A. Jamali, Marion T. Turnbull, Takahisa Kanekiyo, et al.
Journal of Stroke and Cerebrovascular Diseases (2020) Vol. 29, Iss. 4, pp. 104631-104631
Closed Access | Times Cited: 32
From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 309-309
Open Access | Times Cited: 30
A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma
Shiwei Guo, Jing Shen, Junhui Gao, et al.
Surgery (2020) Vol. 168, Iss. 6, pp. 1003-1014
Closed Access | Times Cited: 30
Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling
Zuojing Yin, Xinmiao Yan, Qiming Wang, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 29
Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future
Aline Barhli, Jérôme Cros, Laurent Bartholin, et al.
Digestive and Liver Disease (2018) Vol. 50, Iss. 10, pp. 979-990
Closed Access | Times Cited: 28
Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer
Damiano Caputo, Luca Digiacomo, Chiara Cascone, et al.
Cancers (2020) Vol. 13, Iss. 1, pp. 93-93
Open Access | Times Cited: 26
Neutrophils: Orchestrators of the Malignant Phenotype
Brian E. Hsu, Yunyun Shen, Peter M. Siegel
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 25
Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer
Ye Zang, Yu Fan, Zhenjun Gao
Medicine (2020) Vol. 99, Iss. 23, pp. e20595-e20595
Open Access | Times Cited: 24
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin Hill, Shuchi Sehgal, et al.
Radiation Oncology Journal (2022) Vol. 40, Iss. 2, pp. 111-119
Open Access | Times Cited: 14
LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis
Chun-Ye Chen, Feng Yan, Xing Wang
Clinica Chimica Acta (2018) Vol. 484, pp. 265-271
Closed Access | Times Cited: 26
Improved prognosis of pancreatic cancer patients with peritoneal metastasis
Tsuyoshi Takeda, Takashi Sasaki, Takafumi Mie, et al.
Pancreatology (2021) Vol. 21, Iss. 5, pp. 903-911
Closed Access | Times Cited: 20
Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer
Adam R. Wolfe, Michael Siedow, Ansel P. Nalin, et al.
Radiotherapy and Oncology (2021) Vol. 158, pp. 207-214
Closed Access | Times Cited: 18
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade
Christopher Neumann, F Schneider, Georg Hilfenhaus, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2367-2367
Open Access | Times Cited: 7
Impact on survival of sarcopenia, systemic inflammatory response and anthropometric factors after pancreatectomy for resectable pancreatic adenocarcinoma
Kaja Balcer, Jonathan Garnier, Yasmina Richa, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth—Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen
Richard E. Kast
Cancers (2022) Vol. 14, Iss. 19, pp. 4965-4965
Open Access | Times Cited: 11
Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection
Niccolò Napoli, Emanuele F. Kauffmann, Concetta Cacace, et al.
Updates in Surgery (2020) Vol. 73, Iss. 1, pp. 233-249
Open Access | Times Cited: 17
Prognostic Value of Preoperative NLR and Vascular Reconstructive Technology in Patients With Pancreatic Cancer of Portal System Invasion: A Real World Study
Lin Zhou, Jing Wang, Xinxue Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma
M. Hosein Aziz, Jelle C. van Dongen, Lawlaw Saida, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10

Scroll to top